ABN AMRO Bank N.V. Lowers Holdings in Xylem Inc. $XYL

Key Points

• ABN AMRO Bank trimmed its Xylem stake by 2.4% in the fourth quarter, though it still held 1.6 million shares valued at about $217.3 million. Xylem remained one of the bank’s larger holdings, representing roughly 2% of its portfolio.
• Xylem beat Q1 earnings expectations, posting $1.12 EPS versus estimates of $1.09 and revenue of $2.13 billion versus $2.11 billion expected. The company also raised its quarterly dividend to $0.43 per share and authorized a $1.5 billion share buyback.
• Analyst sentiment remains mixed but constructive, with a consensus rating of Moderate Buy and an average price target of $152.77. Meanwhile, the stock was trading near its 52-week low at $113.76, below both its 50-day and 200-day moving averages.

ABN AMRO Bank N.V. decreased its position in Xylem Inc. (NYSE:XYL - Free Report) by 2.4% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,598,206 shares of the industrial products company's stock after selling 38,890 shares during the period. Xylem accounts for about 2.0% of ABN AMRO Bank N.V.'s investment portfolio, making the stock its 16th biggest position. ABN AMRO Bank N.V. owned approximately 0.66% of Xylem worth $217,317,000 at the end of the most recent reporting period.

A number of other large investors have also recently modified their holdings of XYL. AQR Capital Management LLC lifted its holdings in Xylem by 14.4% during the first quarter. AQR Capital Management LLC now owns 30,955 shares of the industrial products company's stock worth $3,645,000 after buying an additional 3,900 shares during the period. NewEdge Advisors LLC lifted its holdings in Xylem by 3.3% during the first quarter. NewEdge Advisors LLC now owns 4,151 shares of the industrial products company's stock worth $496,000 after buying an additional 132 shares during the period. Empowered Funds LLC lifted its holdings in Xylem by 56.1% during the first quarter. Empowered Funds LLC now owns 8,678 shares of the industrial products company's stock worth $1,037,000 after buying an additional 3,120 shares during the period. Arrowstreet Capital Limited Partnership lifted its holdings in Xylem by 97.6% during the second quarter. Arrowstreet Capital Limited Partnership now owns 11,151 shares of the industrial products company's stock worth $1,442,000 after buying an additional 5,509 shares during the period. Finally, EverSource Wealth Advisors LLC lifted its holdings in Xylem by 114.0% during the second quarter. EverSource Wealth Advisors LLC now owns 1,192 shares of the industrial products company's stock worth $154,000 after buying an additional 635 shares during the period. Hedge funds and other institutional investors own 87.96% of the company's stock.

Analyst Ratings Changes

A number of analysts have weighed in on XYL shares. UBS Group upped their target price on Xylem from $132.00 to $133.00 and gave the stock a "neutral" rating in a report on Wednesday, April 29th. Citigroup lowered their target price on Xylem from $174.00 to $168.00 and set a "buy" rating for the company in a report on Wednesday, April 29th. Mizuho set a $138.00 target price on Xylem in a report on Wednesday, February 11th. Weiss Ratings lowered Xylem from a "hold (c+)" rating to a "hold (c)" rating in a report on Friday. Finally, Royal Bank Of Canada lowered their target price on Xylem from $176.00 to $162.00 and set an "outperform" rating for the company in a report on Wednesday, February 11th. Seven analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company's stock. Based on data from MarketBeat, Xylem currently has a consensus rating of "Moderate Buy" and an average target price of $152.77.

Xylem Stock Up 0.0%

Shares of XYL stock opened at $113.76 on Monday. The stock's 50-day simple moving average is $122.63 and its 200-day simple moving average is $134.10. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.10 and a current ratio of 1.46. The firm has a market capitalization of $27.04 billion, a PE ratio of 28.30, a P/E/G ratio of 1.62 and a beta of 1.08. Xylem Inc. has a fifty-two week low of $113.45 and a fifty-two week high of $154.27.

Xylem (NYSE:XYL - Get Free Report) last announced its quarterly earnings data on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, beating analysts' consensus estimates of $1.09 by $0.03. The business had revenue of $2.13 billion for the quarter, compared to analyst estimates of $2.11 billion. Xylem had a return on equity of 11.26% and a net margin of 10.79%.The company's revenue was up 2.7% on a year-over-year basis. During the same period in the prior year, the company earned $1.03 earnings per share. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. Equities analysts expect that Xylem Inc. will post 5.51 earnings per share for the current year.

Xylem Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 24th. Shareholders of record on Tuesday, February 24th were paid a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.5%. The ex-dividend date was Tuesday, February 24th. This is an increase from Xylem's previous quarterly dividend of $0.40. Xylem's dividend payout ratio (DPR) is 42.79%.

Xylem declared that its Board of Directors has initiated a stock buyback plan on Wednesday, February 25th that authorizes the company to repurchase $1.50 billion in shares. This repurchase authorization authorizes the industrial products company to buy up to 4.8% of its shares through open market purchases. Shares repurchase plans are often an indication that the company's leadership believes its stock is undervalued.

Insider Activity

In other news, CAO Geri-Michelle Mcshane sold 4,269 shares of the business's stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $117.46, for a total value of $501,436.74. Following the completion of the transaction, the chief accounting officer owned 3,605 shares of the company's stock, valued at $423,443.30. The trade was a 54.22% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Jerome A. Peribere acquired 1,210 shares of the firm's stock in a transaction dated Monday, May 4th. The stock was bought at an average cost of $116.61 per share, with a total value of $141,098.10. Following the acquisition, the director owned 27,209 shares in the company, valued at approximately $3,172,841.49. This trade represents a 4.65% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders own 0.32% of the company's stock.

Xylem Company Profile

Xylem Inc NYSE: XYL is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.